EUVIMEDEUVIMED entdecken
Crossref

Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New.

Jonathan R Day, Brian K Link

ONCOLOGY · 2022

DOI: 10.46883/2022.25920947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ONCOLOGY, 2022. Verfasst von Jonathan R Day und 1 weiteren Autor:innen. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalAntineoplastic Agents, ImmunologicalHumansImmunotherapy, AdoptiveLymphoma, FollicularMolecular Targeted TherapyProtein Kinase Inhibitors

Substanzen

Antibodies, MonoclonalAntineoplastic Agents, ImmunologicalProtein Kinase Inhibitors

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Day, J. R., & Link, B. K. (2022). Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New. ONCOLOGY. https://doi.org/10.46883/2022.25920947

Vancouver

Day JR, Link BK. Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New. ONCOLOGY. 2022. doi:10.46883/2022.25920947

BibTeX
@article{Day2022,
  author = {Day, Jonathan R and Link, Brian K},
  title = {Perspectives on Follicular Lymphoma Treatment From New and Experienced Clinicians: New, Old, & Old Is New},
  journal = {ONCOLOGY},
  year = {2022},
  doi = {10.46883/2022.25920947}
}
Kostenlos starten →